Outcome Measures of New Technologies in Uveal Melanoma: Review from the European Vision Institute Special Interest Focus Group Meeting

Jan-Willem M Beenakker*, Niels J Brouwer, Cindy Chau, Sarah E Coupland, Miltiadis Fiorentzis, Heinrich Heimann, Jens Heufelder, Antonia M Joussen, Jens F Kiilgaard, Tero T Kivelä, Sophie Piperno-Neumann, Elina S Rantala, Bozena Romanovska-Dixon, Carol L Shields, Gregor D Willerding, Thomas Wheeler-Schilling, Hendrik P N Scholl, Martine J Jager, Bertil E Damato

*Corresponding author af dette arbejde

Abstract

Uveal Melanoma (UM) is the most common primary intra-ocular tumor in adults. New diagnostic procedures and basic science discoveries continue to change our patient management paradigms. A recent meeting of the European Vision Institute (EVI) special interest focus group was held on "Outcome Measures of New Technologies in Uveal Melanoma", addressing the latest advances in UM, starting with genetic developments, then moving on to imaging and treatment of the primary tumor, as well as to investigating the most recent developments in treating metastases, and eventually taking care of the patient's wellbeing. This review highlights the meeting's presentations in the context of the published literature.

OriginalsprogEngelsk
TidsskriftOphthalmic Research
Vol/bind66
Udgave nummer1
Sider (fra-til)14-26
Antal sider13
ISSN0030-3747
DOI
StatusUdgivet - 2023

Fingeraftryk

Dyk ned i forskningsemnerne om 'Outcome Measures of New Technologies in Uveal Melanoma: Review from the European Vision Institute Special Interest Focus Group Meeting'. Sammen danner de et unikt fingeraftryk.

Citationsformater